top of page

Insights & Perspectives
Insights & perspectives features MCRA Member contributions, organizational updates, and informed viewpoints on the issues influencing healthcare today. It’s where MCRA Members share expertise, progress, and perspective.
Search


From Policy to Member Action: Preparing for Medicaid Community Engagement Requirements
MCRA Members Avalere Health and Command Direct engaged in a panel discussion moderated by Desiree Vuocolo, Director of Programs and Partnerships. They discussed new Medicaid community engagement requirements.
Oct 251 min read


The Future of Medicaid: What Policy Changes Mean for Managed Care
Medicaid is entering a period of significant change. New work requirements, shifting financing models, rising healthcare costs, and growing pressure on state budgets are creating new challenges for managed care organizations, while the need to improve access, experience, and outcomes remains as important as ever.
MCRA Members GoMo Health and Avalere Health team up to offer insights on the Medicaid policy changes and how managed care organizations can respond.
Sep 241 min read


Medicaid work requirements and how states may apply them: An in-depth discussion with Eric Levine, M.P.H., of Avalere Health
Avalere Health explains some of the details of Medicaid work requirements, including how activities of daily living may factor in and some of the leeway states have in how they are applied.
Aug 128 min read


Medicaid Work Requirements: Understanding Exemptions and Protecting Patients
Medicaid work requirements are expected to start January 2027, with narrower exemptions than anticipated. Learn how life sciences companies, plans, and providers can support patients.
Aug 63 min read


Post-Clover and 2027 QBP Re-Calculation: What Could Be Next for MA Stars?
CMS will be re-calculating 2027 QBP ratings following the May 2026 Clover ruling. Avalere Health experts share insights on potential future directions for the MA Star Rating program.
Jul 223 min read


Part B Negotiated Drug Prices: How MA Plans Should Prepare
Part B drugs will be subject to IRA price negotiation for the first time in 2028, introducing new payment uncertainties for Medicare Advantage plans.
Jul 174 min read
bottom of page
